Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Ajovy |
| Active Ingredient: | Fremanezumab 150mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany |
| Product: | Ferrous Fumarate/Folic Acid |
| Active Ingredients: | Ferrous fumarate 310mg equivalent to 100 mg elemental iron Folic acid 0.35mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Neo Pharma Limited |
| Manufacturer: | Titan Laboratories Pvt Limited, Jite, India |
Dated this 21st day of March 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).